Financial Results

Key highlights

Filter

Period

Filter by

recent search

Showing: 105 of 24 Financial Results

Ipsen reports solid sales growth in first quarter 2020 with limited COVID-19 impact
Ipsen reports solid sales growth in first quarter 2020 with limited COVID-19 impact

Paris (France), 22 April 2020 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced its sales for the first quarter of 2020.


Ipsen presents its 2019 results, provides 2020 guidance and updates 2022 financial outlook
Ipsen presents its 2019 results, provides 2020 guidance and updates 2022 financial outlook

Aymeric Le Chatelier, Chief Executive Officer and Chief Financial Officer of Ipsen, stated: “2019 was another excellent year of operating performance for Ipsen with continued double-digit top-line growth and core operating margin expansion. Despite the recent palovarotene setback, the fundamentals of…





Your dedicated contacts